Market Indices
Sector Heatmap
RLAY — Relay Therapeutics, Inc. Common Stock
NasdaqRelay Therapeutics, Inc. Common Stock
- O
- 17.71
- H
- 17.97
- L
- 16.87
- V
- 4.33M
RLAY — Latest News & Headlines
20 StoriesRLAY: Relay Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
RLAY: Relay Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits
Relay Therapeutics (RLAY) Stock Looks Fully Priced On Book Value - Yahoo Finance
Relay Therapeutics (RLAY) Stock Looks Fully Priced On Book Value Yahoo Finance
After two share sales, Sanjiv Patel proposes another at Relay Therapeutics (RLAY). - Stock Titan
After two share sales, Sanjiv Patel proposes another at Relay Therapeutics (RLAY). Stock Titan
Why Is RLAY Stock Rising Today? - Stocktwits
Why Is RLAY Stock Rising Today? Stocktwits
Relay Therapeutics (RLAY) Pullback Puts Its Vascular Anomalies Valuation Narrative To The Test - Simply Wall Street
Relay Therapeutics (RLAY) Pullback Puts Its Vascular Anomalies Valuation Narrative To The Test Simply Wall Street
(RLAY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
(RLAY) and the Role of Price-Sensitive Allocations Stock Traders Daily
Possible Bearish Signals With Relay Therapeutics Insiders Disposing Stock - Moomoo
Possible Bearish Signals With Relay Therapeutics Insiders Disposing Stock Moomoo
PERCEPTIVE ADVISORS LLC's Relay Therapeutics Inc(RLAY) Holding History - GuruFocus
PERCEPTIVE ADVISORS LLC's Relay Therapeutics Inc(RLAY) Holding History GuruFocus
CEO sells 48,199 shares under a trading plan at Relay Therapeutics (RLAY). - Stock Titan
CEO sells 48,199 shares under a trading plan at Relay Therapeutics (RLAY). Stock Titan
Is Relay Therapeutics (RLAY) Cheap After Its Pullback Or Is The Upside Priced In? - Yahoo Finance
Is Relay Therapeutics (RLAY) Cheap After Its Pullback Or Is The Upside Priced In? Yahoo Finance
(RLAY) Risk Channels and Responsive Allocation - Stock Traders Daily
(RLAY) Risk Channels and Responsive Allocation Stock Traders Daily
Relay Therapeutics stock fell 3.35 percent as officer filed to sell shares - AD HOC NEWS
Relay Therapeutics stock fell 3.35 percent as officer filed to sell shares AD HOC NEWS
JonesTrading Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $20 - Moomoo
JonesTrading Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $20 Moomoo
After two 17,717-share sales, a Relay Therapeutics (RLAY) officer proposes another sale. - Stock Titan
After two 17,717-share sales, a Relay Therapeutics (RLAY) officer proposes another sale. Stock Titan
RLAY Dec 2026 16.000 call (RLAY261218C00016000) Interactive Stock Chart - Yahoo! Finance Canada
RLAY Dec 2026 16.000 call (RLAY261218C00016000) Interactive Stock Chart Yahoo! Finance Canada
Under a trading plan, Relay Therapeutics (RLAY) CFO sells 17,511 shares plus 206 more. - Stock Titan
Under a trading plan, Relay Therapeutics (RLAY) CFO sells 17,511 shares plus 206 more. Stock Titan
RLAY Oct 2026 16.000 put (RLAY261016P00016000) Stock Historical Prices & Data - Yahoo! Finance Canada
RLAY Oct 2026 16.000 put (RLAY261016P00016000) Stock Historical Prices & Data Yahoo! Finance Canada
RLAY280121P00017000 Interactive Stock Chart | RLAY Jan 2028 17.000 put Stock - Yahoo! Finance Canada
RLAY280121P00017000 Interactive Stock Chart | RLAY Jan 2028 17.000 put Stock Yahoo! Finance Canada
RLAY261016P00016000 interactive stock chart | RLAY Oct 2026 16.000 put stock - Yahoo Finance Australia
RLAY261016P00016000 interactive stock chart | RLAY Oct 2026 16.000 put stock Yahoo Finance Australia
Relay Therapeutics Tumbles After Deeply Discounted Stock Sale - TipRanks
Relay Therapeutics Tumbles After Deeply Discounted Stock Sale TipRanks